Stephanie L Gaillard

Title: Stephanie L. Gaillard: Innovator in Breast Cancer Treatment

Introduction

Stephanie L. Gaillard is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of cancer treatment, particularly focusing on estrogen receptor positive breast cancer. With a total of 6 patents to her name, her work is paving the way for innovative therapeutic approaches.

Latest Patents

One of her latest patents involves the use of lasofoxifene for the treatment of breast cancer. This patent outlines methods for treating estrogen receptor positive (ER) cancer in women using an effective amount of lasofoxifene, a pharmaceutically acceptable salt, or a prodrug. Additionally, the patent includes the detection of Estrogen Receptor 1 (ESR1) gene mutations that contribute to endocrine resistance, providing a pathway for treating endocrine resistant ER cancers.

Career Highlights

Stephanie is affiliated with Duke University, where she continues her research and development in cancer therapies. Her work is characterized by a commitment to improving treatment outcomes for patients with breast cancer.

Collaborations

She collaborates with notable colleagues, including Kaitlyn Andreano and Ching-yi Chang, who contribute to her research efforts and innovations in the field.

Conclusion

Stephanie L. Gaillard's contributions to breast cancer treatment through her innovative patents and research at Duke University highlight her role as a leading inventor in the medical field. Her work continues to inspire advancements in cancer therapies.